Liver
North American panel proposes new framework for allocating liver cancer treatment

  • September 3

UnitedHealthcare to end GI endoscopy advance notification, site-of-service reviews

  • September 1

Colon
Colonoscopy screening lowered colorectal cancer incidence 19% over 13 years

  • September 2

Esophagus
Sustainability in endoscopy

  • September 1

Colon

Six-trial analysis finds no new upadacitinib safety signals in IBD

  • September 3

Shingles rates climbed with dose — 6.6 events per 100 patient-years at 30 mg vs. 1.9 with placebo — while blood clots, cardiovascular events, and cancers stayed uncommon.

BROWSE BY TOPICS

The New Gastroenterologist

Substance use disorders in gastroenterology and hepatology: A practical guide for the general gastroenterologist

  • August 3

  • by Isabelle S. Byers, MD, Michelle Russin, MD, Sasha Deutsch-Link, MD, MSCR

GI and liver complications often bring these patients in first, and the authors say gastroenterologists are well placed to screen and treat.

Esophagus
Bridging the rural divide: Building a motility center in a critical access hospital

  • August 3

  • by Amber Charoen, MD, W. Michael McDonnell, MD, AGAF

“If large urban centers can run comprehensive motility labs, why can't a critical access hospital?”

Is professional coaching worth it? A practical guide for early-career gastroenterologists

  • August 3

  • by Mariam Naveed, MD, FACG, Kathryn E. Hutchins, MD, FACG

Two program directors on why coaching belongs at the start of a GI career, not after something has already gone wrong.

The Latest

September 7
Stomach
HLA typing may help identify past celiac disease misdiagnoses

  • by Doug Brunk

All newly diagnosed patients in a Norwegian screening study carried a known genetic risk type, while 6% of those diagnosed years earlier carried none.

September 4
Liver
Machine learning model shrinks portal hypertension gray zone

  • by Doug Brunk

New pan-elastography model improves noninvasive identification of patients who may benefit from beta-blocker therapy while reducing indeterminate results across multiple elastography platforms.

September 3
Liver
North American panel proposes new framework for allocating liver cancer treatment

  • by Jess Allerton

BEACON-HCC gives radiation-based therapies a larger first-line role and reserves curative options for some patients BCLC classifies as advanced.

September 3
Colon
Six-trial analysis finds no new upadacitinib safety signals in IBD

  • by Doug Brunk

Shingles rates climbed with dose — 6.6 events per 100 patient-years at 30 mg vs. 1.9 with placebo — while blood clots, cardiovascular events, and cancers stayed uncommon.

September 2
Colon
Colonoscopy screening lowered colorectal cancer incidence 19% over 13 years

  • by Julie Greenbaum

“Screening might be justified if it prevents people from getting cancer even without reducing the risk of dying.”